Comparison of Effective Radiation Doses from X-Ray, CT, and PET/ CT in Pediatric Patients with Neuroblastoma Using a Dose Monitoring Program

Total Page:16

File Type:pdf, Size:1020Kb

Comparison of Effective Radiation Doses from X-Ray, CT, and PET/ CT in Pediatric Patients with Neuroblastoma Using a Dose Monitoring Program Diagn Interv Radiol 2016; 22:390–394 PEDIATRIC RADIOLOGY © Turkish Society of Radiology 2016 ORIGINAL ARTICLE Comparison of effective radiation doses from X-ray, CT, and PET/ CT in pediatric patients with neuroblastoma using a dose monitoring program Yeun Yoon Kim PURPOSE Hyun Joo Shin We aimed to evaluate the use of a dose monitoring program for calculating and comparing the Myung-Joon Kim diagnostic radiation doses in pediatric patients with neuroblastoma. Mi-Jung Lee METHODS We retrospectively reviewed diagnostic and therapeutic imaging studies performed on pediatric patients with neuroblastoma from 2003 to 2014. We calculated the mean effective dose per exam for X-ray, conventional computed tomography (CT), and CT of positron emission tomography/com- puted tomography (PET/CT) from the data collected using a dose monitoring program (DoseTrack group) since October 2012. Using the data, we estimated the cumulative dose per person and the relative dose from each modality in all patients (Total group). The effective dose from PET was man- ually calculated for all patients. RESULTS We included 63 patients with a mean age of 3.2±3.5 years; 28 had a history of radiation therapy, with a mean irradiated dose of 31.9±23.2 Gy. The mean effective dose per exam was 0.04±0.19 mSv for X-ray, 1.09±1.11 mSv for CT, and 8.35±7.45 mSv for CT of PET/CT in 31 patients of the Dose- Track group. The mean estimated cumulative dose per patient in the Total group was 3.43±2.86 mSv from X-ray (8.5%), 7.66±6.09 mSv from CT (19.1%), 18.35±13.52 mSv from CT of PET/CT (45.7%), and 10.71±10.05 mSv from PET (26.7%). CONCLUSION CT of PET/CT contributed nearly half of the total cumulative dose in pediatric patients with neuro- blastoma. The radiation dose from X-ray was not negligible because of the large number of X-ray images. A dose monitoring program can be useful for calculating radiation doses in patients with cancer. adiation exposure in children may cause more serious consequences than in adults. The risk of radiation-induced cancer mortality is significantly higher per unit dose in R children than in adults because this risk increases inversely with age (1). There are sev- eral established reasons for this phenomenon. First, children are innately more vulnerable to develop secondary malignancies. For example, an infant has more than 10 times the risk of cancer induction with the same radiation dose compared with an adult (2). The risk of developing secondary fatal malignancies in children around the age of 10 years is approxi- mately 15% per Sievert (Sv), which is four times higher than that for adults in their forties (2). Second, children have a longer lifespan to develop malignancies after exposure, and most solid cancers have a latency of at least a decade (3). In addition, gonadal irradiation causes more genetic damage in children than in adults (4). Radiotherapy is the main risk factor for the development of solid second malignant neo- plasms within the irradiated body region (5, 6). However, the increasing use of diagnostic imag- From the Department of Radiology and Research ing studies with ionizing radiation in pediatric practice also raises the issue of radiation hazards Institute of Radiological Science (M.J.L. mjl1213@ yuhs.ac) Severance Children’s Hospital, Yonsei (7). The radiation dose from diagnostic computed tomography (CT) is positively correlated with University College of Medicine, Seoul, Korea. cancer induction in children (8). Moreover, compared with adult CT, pediatric CT may sharply increase the estimated risk of cancer mortality (9). In addition, the use of serial positron emis- Received 28 May 2015; revision requested 23 July 2015; last revision received 11 November 2015; sion tomography/computed tomography (PET/CT) in children with malignancies has also accepted 3 December 2015. raised concerns regarding the harmful effects of a considerable amount of radiation. Published online 14 June 2016. Neuroblastoma is the most common extracranial solid cancer in childhood (10). The cu- DOI 10.5152/dir.2015.15221 mulative radiation dose from frequent imaging studies using ionizing radiation may lead to 390 serious problems in pediatric patients with to compare the radiation dose from each factors from the National Radiological cancer. As the survival rates of pediatric pa- modality. Protection Board-R262 for X-ray and the tients with solid tumors have dramatically International Commission on Radiological increased over the last several decades Methods Protection (ICRP) 102 for conventional CT (11), the long-term consequences of radi- Patients and examinations and CT of PET/CT. The radiation dose from ation exposure from serial imaging studies The Institutional Review Board of Sever- PET was calculated by multiplying the fluo- in these patients have become more im- ance hospital approved this retrospective rodeoxyglucose activity by the dose coeffi- portant. In addition, PET/CT has emerged study and required neither patient approv- cient. The fluorodeoxyglucose activity was as an important diagnostic tool for neuro- al nor informed consent for reviewing the assumed to be 5 MBq per body weight in blastoma (12, 13). Conventional imaging patients’ images and medical records. We kg (16), and we used the tissue weighting protocols for neuroblastoma include not searched the electronic medical record in factors from ICRP 103. only CT but also PET/CT before and after our institution from January 2008 to Octo- Radiation dose data from this program treatment, on follow-up, or for evaluation ber 2014 to collect information from pediat- was available from October 2012 in our hos- of recurrence (14). Therefore, precise calcu- ric patients with pathologically diagnosed pital. For patients with exams performed lation and monitoring of the radiation dose neuroblastoma since records from 2008 after October 2012, the radiation dose was from imaging studies that use ionizing ra- were available for retrieval in the electronic calculated using the DoseTrack program diation in each neuroblastoma patient are system. We reviewed the medical records of (DoseTrack group). We collected the effec- important. However, it is difficult to manu- these children for age at the time of diagno- tive dose data by modality per patient us- ally calculate the radiation dose from each sis, gender, organ of tumor origin, and body ing the program and calculated the mean modality in each patient. weight on the day of PET or PET/CT. In ad- effective dose per X-ray, conventional CT, Recently developed dose monitoring dition, we reviewed the history of radiation and CT of PET/CT examination. For studies software collects dose information from therapy, with irradiated dose and duration. performed before October 2012, the effec- each patient, either directly from the mo- Furthermore, we reviewed the diagnos- tive dose was estimated by applying the dality or through the radiology information tic imaging studies performed on these mean dose per exam calculated by the data system, picture archiving and communica- children to collect the acquisition number from the DoseTrack group. We calculated tion system (PACS), or electronic medical of each imaging modality from 2003 to the mean cumulative radiation dose per records. Using dose monitoring programs, December 2014 because PACS (Centricity; person and the relative doses from X-ray, it is possible to calculate, report, and mon- GE Healthcare) was adopted at our hospi- conventional CT, and CT of PET/CT in all pa- itor radiation doses, including the effective tal in 2003. We included diagnostic imag- tients (Total group). dose, more easily than before (15). Howev- ing studies with ionizing radiation, such er, few studies have evaluated these pro- as X-ray, conventional CT, PET, and PET/CT, Statistical analysis grams in clinical practice. and those without ionizing radiation, such We used descriptive statistics for age, du- This study aimed to evaluate the utility of as ultrasonography and magnetic reso- ration and number of imaging studies, and a dose monitoring program for calculating nance imaging (MRI). We did not evaluate doses from diagnostic imaging studies or and monitoring the effective radiation dose the radiation dose from other nuclear med- radiotherapy. Statistical analysis was per- from diagnostic imaging studies, including icine imaging studies except PET or PET/ formed using SPSS Statistics (version 20.0, X-ray, conventional CT, and CT of PET/CT, in CT because of the different methodologies IBM Corp.) to evaluate data normality and pediatric patients with neuroblastoma and used to calculate the radiation dose in these calculate mean values with standard devi- studies and the limited clinical information ations. Relative doses between X-ray, CT, CT Main points regarding the old data. We calculated the of PET/CT, and PET were summarized using total duration of exams for each patient. simple proportions. • PET and PET/CT contributed to more than 70% of the total diagnostic radiation doses in pediatric neuroblastoma patients. Dose calculation and analysis Results • The average cumulative dose per patient We used a commercially available dose The study included 63 patients (39 males from CT of PET/CT was 18.35 mSv, which monitoring program (DoseTrack; version and 24 females) from January 2008 to Oc- accounted for 46% of the total dose and was 1.0, 2012, GE Healthcare) to calculate the tober 2014. The mean age at the time of greater than twice of the average cumulative effective dose from X-ray, conventional CT, diagnosis was 3.2±3.5 years. The organs of dose of 7.66 mSv from conventional CT. and CT of PET/CT in each patient. The pro- tumor origin were as follows: adrenal gland • Patient irradiation should be considered gram monitors radiation doses from all im- (n=44), mediastinum (n=10), retroperitone- when selecting the imaging modality and aging modalities using ionizing radiation.
Recommended publications
  • Personal Radiation Monitoring
    Personal Radiation Monitoring Tim Finney 2020 Radiation monitoring Curtin staff and students who work with x-ray machines, neutron generators, or radioactive substances are monitored for exposure to ionising radiation. The objective of radiation monitoring is to ensure that existing safety procedures keep radiation exposure As Low As Reasonably Achievable (ALARA). Personal radiation monitoring badges Radiation exposure is measured using personal radiation monitoring badges. Badges contain a substance that registers how much radiation has been received. Here is the process by which a user’s radiation dose is measured: 1. The user is given a badge to wear 2. The user wears the badge for a set time period (usually three months) 3. At the end of the set time, the user returns the badge 4. The badge is sent away to be read 5. A dose report is issued. These steps are repeated until monitoring is no longer required. Badges are supplied by a personal radiation monitoring service provider. Curtin uses a service provider named Landauer. In addition to user badges, the service provider sends control badges that are kept on site in a safe place away from radiation sources. The service provider reads each badge using a process that extracts a signal from the substance contained in the badge to obtain a dose measurement. (Optically stimulated luminescence is one such process.) The dose received by the control badge is subtracted from the user badge reading to obtain the user dose during the monitoring period. Version 1.0 Uncontrolled document when printed Health and Safety Page 1 of 7 A personal radiation monitoring badge Important Radiation monitoring badges do not protect you from radiation exposure.
    [Show full text]
  • Proper Use of Radiation Dose Metric Tracking for Patients Undergoing Medical Imaging Exams
    Proper Use of Radiation Dose Metric Tracking for Patients Undergoing Medical Imaging Exams Frequently Asked Questions Introduction In August of 2021, the American Association of Physicists in Medicine (AAPM), the American College of Radiology (ACR), and the Health Physics Society (HPS) jointly released the following position statement advising against using information about a patient’s previous cumulative dose information from medical imaging exams to decide the appropriateness of future imaging exams. This statement was also endorsed by the Radiological Society of North America (RSNA). It is the position of the American Association of Physicists in Medicine (AAPM), the American College of Radiology (ACR), and the Health Physics Society (HPS) that the decision to perform a medical imaging exam should be based on clinical grounds, including the information available from prior imaging results, and not on the dose from prior imaging-related radiation exposures. AAPM has long advised, as recommended by the International Commission on Radiological Protection (ICRP), that justification of potential patient benefit and subsequent optimization of medical imaging exposures are the most appropriate actions to take to protect patients from unnecessary medical exposures. This is consistent with the foundational principles of radiation protection in medicine, namely that patient radiation dose limits are inappropriate for medical imaging exposures. Therefore, the AAPM recommends against using dose values, including effective dose, from a patient’s prior imaging exams for the purposes of medical decision making. Using quantities such as cumulative effective dose may, unintentionally or by institutional or regulatory policy, negatively impact medical decisions and patient care. This position statement applies to the use of metrics to longitudinally track a patient’s dose from medical radiation exposures and infer potential stochastic risk from them.
    [Show full text]
  • Cumulative Radiation Dose in Patients Admitted with Subarachnoid Hemorrhage: a Prospective PATIENT SAFETY Study Using a Self-Developing Film Badge
    Cumulative Radiation Dose in Patients Admitted with Subarachnoid Hemorrhage: A Prospective PATIENT SAFETY Study Using a Self-Developing Film Badge A.C. Mamourian BACKGROUND AND PURPOSE: While considerable attention has been directed to reducing the x-ray H. Young dose of individual imaging studies, there is little information available on the cumulative dose during imaging-intensive hospitalizations. We used a radiation-sensitive badge on 12 patients admitted with M.F. Stiefel SAH to determine if this approach was feasible and to measure the extent of their x-ray exposure. MATERIALS AND METHODS: After obtaining informed consent, we assigned a badge to each of 12 patients and used it for all brain imaging studies during their ICU stay. Cumulative dose was deter- mined by quantifying exposure on the badge and correlating it with the number and type of examinations. RESULTS: The average skin dose for the 3 patients who had only diagnostic DSA without endovascular intervention was 0.4 Gy (0.2–0.6 Gy). The average skin dose of the 8 patients who had both diagnostic DSA and interventions (eg, intra-arterial treatment of vasospasm and coiling of aneurysms) was 0.9 Gy (1.8–0.4 Gy). One patient had only CT examinations. There was no effort made to include or exclude the badge in the working view during interventions. CONCLUSIONS: It is feasible to incorporate a film badge that uses a visual scale to monitor the x-ray dose into the care of hospitalized patients. Cumulative skin doses in excess of 1 Gy were not uncommon (3/12) in this group of patients with acute SAH.
    [Show full text]
  • Radiation Glossary
    Radiation Glossary Activity The rate of disintegration (transformation) or decay of radioactive material. The units of activity are Curie (Ci) and the Becquerel (Bq). Agreement State Any state with which the U.S. Nuclear Regulatory Commission has entered into an effective agreement under subsection 274b. of the Atomic Energy Act of 1954, as amended. Under the agreement, the state regulates the use of by-product, source, and small quantities of special nuclear material within said state. Airborne Radioactive Material Radioactive material dispersed in the air in the form of dusts, fumes, particulates, mists, vapors, or gases. ALARA Acronym for "As Low As Reasonably Achievable". Making every reasonable effort to maintain exposures to ionizing radiation as far below the dose limits as practical, consistent with the purpose for which the licensed activity is undertaken. It takes into account the state of technology, the economics of improvements in relation to state of technology, the economics of improvements in relation to benefits to the public health and safety, societal and socioeconomic considerations, and in relation to utilization of radioactive materials and licensed materials in the public interest. Alpha Particle A positively charged particle ejected spontaneously from the nuclei of some radioactive elements. It is identical to a helium nucleus, with a mass number of 4 and a charge of +2. Annual Limit on Intake (ALI) Annual intake of a given radionuclide by "Reference Man" which would result in either a committed effective dose equivalent of 5 rems or a committed dose equivalent of 50 rems to an organ or tissue. Attenuation The process by which radiation is reduced in intensity when passing through some material.
    [Show full text]
  • ``Low Dose``And/Or``High Dose``In Radiation Protection: a Need To
    IAEA-CN-67/154 "LOW DOSE" AND/OR "HIGH DOSE" IN RADIATION PROTECTION: A NEED TO SETTING CRITERIA FOR DOSE CLASSIFICATION Mehdi Sohrabi National Radiation Protection Department & XA9745670 Center for Research on Elevated Natural Radiation Atomic Energy Organization of Iran, Tehran ABSTRACT The "low dose" and/or "high dose" of ionizing radiation are common terms widely used in radiation applications, radiation protection and radiobiology, and natural radiation environment. Reading the title, the papers of this interesting and highly important conference and the related literature, one can simply raise the question; "What are the levels and/or criteria for defining a low dose or a high dose of ionizing radiation?". This is due to the fact that the criteria for these terms and for dose levels between these two extreme quantities have not yet been set, so that the terms relatively lower doses or higher doses are usually applied. Therefore, setting criteria for classification of radiation doses in the above mentioned areas seems a vital need. The author while realizing the existing problems to achieve this important task, has made efforts in this paper to justify this need and has proposed some criteria, in particular for the classification of natural radiation areas, based on a system of dose limitation. In radiation applications, a "low dose" is commonly associated to applications delivering a dose such as given to a patient in a medical diagnosis and a "high dose" is referred to a dose in applications such as radiotherapy, mutation breeding, control of sprouting, control of insects, delay ripening, and sterilization having a range of doses from 1 to 105 Gy, for which the term "high dose dosimetry" is applied [1].
    [Show full text]
  • Internal and External Exposure Exposure Routes 2.1
    Exposure Routes Internal and External Exposure Exposure Routes 2.1 External exposure Internal exposure Body surface From outer space contamination and the sun Inhalation Suspended matters Food and drink consumption From a radiation Lungs generator Radio‐ pharmaceuticals Wound Buildings Ground Radiation coming from outside the body Radiation emitted within the body Radioactive The body is equally exposed to radiation in both cases. materials "Radiation exposure" refers to the situation where the body is in the presence of radiation. There are two types of radiation exposure, "internal exposure" and "external exposure." External exposure means to receive radiation that comes from radioactive materials existing on the ground, suspended in the air, or attached to clothes or the surface of the body (p.25 of Vol. 1, "External Exposure and Skin"). Conversely, internal exposure is caused (i) when a person has a meal and takes in radioactive materials in the food or drink (ingestion); (ii) when a person breathes in radioactive materials in the air (inhalation); (iii) when radioactive materials are absorbed through the skin (percutaneous absorption); (iv) when radioactive materials enter the body from a wound (wound contamination); and (v) when radiopharmaceuticals containing radioactive materials are administered for the purpose of medical treatment. Once radioactive materials enter the body, the body will continue to be exposed to radiation until the radioactive materials are excreted in the urine or feces (biological half-life) or as the radioactivity weakens over time (p.26 of Vol. 1, "Internal Exposure"). The difference between internal exposure and external exposure lies in whether the source that emits radiation is inside or outside the body.
    [Show full text]
  • Radiation Safety
    Ionizing Radiation Exposure from Radiologic Imaging Background The current and common unit of measurement of “absorbed” ionizing radiation is a milliSievert (mSv). Chest, abdomen or The increased use of diagnostic imaging requiring the use of pelvis CTs will typically expose one to between 6 – 8 mSv. “ionizing radiation,” the rapidly expanding use of computed tomography in the emergency setting, the introduction Specifically, a CT coronary angiogram may carry an of multi-detector CT units and newly reported concerns overall effective radiation dose in a 20 mSv range; the related to the human consequences of low-level radiation organ equivalent dose is quite different.7 Anthromorphic exposure have revitalized a long-standing concern over the mathematical phantoms have shown that such studies quantification and management of an individual’ s cumulative will expose 20-year-old female breast tissue to an organ 1,2,3 “medical” radiation exposure. Studies have shown that equivalent dose of 75 – 80 mSv, and lung tissue as high as 90 many physicians, including radiologists, have developed a mSv. The cancer incidence for a 20-year-old in this example is misconception that the shorter imaging acquisition times believed to be in the one in 143 range…quite significant! With have resulted in lower doses of radiation, when in fact many improvements in technology and CCTA imaging protocols, times the opposite is true. The multi-detector CT units today, effective dose has been reduced significantly, to less than 10 even with shorter scan times, expose patients to higher doses mSv in many cases. of radiation per scan than earlier units.
    [Show full text]
  • Cumulative Radiation Exposure and Your Patient
    Imaging Guideline JANUAry 2013 Cumulative Radiation Exposure and Your Patient This document, developed by Intermountain Healthcare’s Cardiovascular Clinical Program and Imaging Clinical Service, provides information on the cumulative radiation exposure reported in HELP2: the limitations of this information, why Intermountain is measuring and reporting it, tips on interpreting this information, and factors to consider when choosing an imaging procedure. Information in this document (click each item below to skip to that section): Please note that while this 1 What’s included — and not included — in your patient’s document provides evidence- cumulative radiation exposure as reported in HELP2 based information to consider in making treatment 2 Why Intermountain is measuring and reporting cumulative decisions for most patients, radiation exposure your approach should be adapted to meet the needs 3 The risks of radiation exposure of individual patients and 4 Factors to consider when choosing an imaging test situations, and should not 5 Discussing this information with your patient replace clinical judgment. 6 Estimated radiation exposures and lifetime risks from common procedures — a quick reference with resources A brief overview of this 1 WHAT’S INCLUDED IN MY PATIENT’S REPORTED topic is also available. For basic, concise information CUMULATIVE RADIATION EXPOSURE? on radiation exposure and The number reported for each patient: risk, see the brief Physician’s Guide to Radiation Exposure. • Includes four types of relatively higher-dose procedures: CT studies, angiography, nuclear cardiology, and cardiac catheterization procedures. • Begins in mid-2012: Earlier exposures are not included. • Does NOT include: Procedures performed at non-Intermountain facilities, other procedures besides the four listed above, or radiation (oncology) treatments.
    [Show full text]
  • Techniques to Estimate Radiation Dose to Skin During Fluoroscopically Guided Procedures
    Skin Dose Measurements AAPM July 2002 1 of 10 α Techniques to estimate radiation dose to skin during fluoroscopically guided procedures . Stephen Balter1 Douglas W. Fletcher2, Hsin M. Kuan3, Donald Miller2,4 , Detlev Richter5, Hannes Seissl5, Thomas B. Shope, Jr.6,Ω 1. Introduction Fluoroscopically guided invasive procedures are an essential part of medicine. Until the late 1980’s, most of these were relatively low dose diagnostic procedures. Patient radiation safety issues focused on the risks of stochastic injury. Deterministic effects were rare and usually attributable to malfunctioning equipment. The substantial use of fluoroscopy to guide interventional procedures began in the eighties with the widespread adoption of balloon angioplasty. By 1990, radiation induced skin injury became a concern (American College of Radiology 1993). Initially, attention was focused on malfunctioning equipment and high dose-rate techniques. By the mid 90’s the most likely cause was seen to be long procedures conducted at ‘normal’ dose rates (Food and Drug Administration 1994 and 1995; Koenig, Mettler, and Wagner 2001; Lichtenstein et al.1996; Huda 1994). Evidence for chronic skin injury began to emerge by the end of the second millennium (Vañó et al. 2001). Dosimetric information is helpful at multiple levels. Equipment manufacturers can only build equipment within the limits of the laws of nature and available technology. The standards and regulatory systems place safety and performance baselines to assure at least minimum implementations. Fortunately, most modern interventional equipment exceeds these minimums. The physics acceptance testing and QA processes assure dose-rate limits on clinical equipment. Post-procedure tools provide valuable feedback both into the quality improvement process and in the supervision of individual patients.
    [Show full text]
  • Glossary of Radiation Terms
    Glossary of Radiation Terms Activation The process of making a radioisotope by bombarding a stable element with neutrons, protons, or other types of radiation. Agreement State A state that has signed an agreement with the Nuclear Regulatory Commission under which the state regulates the use of by-product, source and small quantities of special nuclear material within that state. Air sampling The collection of samples to detect the presence of, and/or to measure the quantity of volatile or solid radioactive material, non-radioactive particulate matter, or various chemical pollutants in the air. Airborne radioactivity A room, enclosure, or area in which airborne radioactive materials, area composed wholly or partly of licensed material, exist in concentrations that: (1) Exceed the derived air concentration limits, or (2) Would result in an individual present in the area without respiratory protection exceeding, during the hours the individual is present in the area, 0.6 percent of the annual limit on intake or 12 derived air concentration-hours. ALARA Acronym for "As Low As Reasonably Achievable," means making every reasonable effort to maintain exposures to ionizing radiation as far below the dose limits as practical, consistent with the purpose for which the licensed activity is undertaken, taking into account the state of technology, the economics of improvements in relation to state of technology, the economics of improvements in relation to benefits to the public health and safety, and other societal and socioeconomic considerations, and in relation to utilization of nuclear energy and licensed materials in the public interest. Alpha particle A positively charged particle ejected spontaneously from the nuclei of some radioactive elements.
    [Show full text]
  • Generic Ltrhead-Clinic
    Your Annual Dosimetry Badge Summary Report What is this report? This report summarizes the total occupational radiation dose you received from your work with X-rays and radioactive materials at Cornell in the most recent calendar year. Why am I receiving it? State regulations require us to provide individuals monitored for occupational radiation dose an annual summary report of their dose. You can also check your radiation dose online at any time during the year following the instructions at the web portal. What should I do with it? Read the report and contact the Radiation Safety Group if you have questions or concerns: • [email protected] • 607-255-8200 What information is important for me to look at? Your occupational radiation dose from external sources of radiation is summarized on the right side of the form under “Doses (in rem).” The most important values for you to look at are: • Deep Dose Equivalent (DDE): external radiation dose at a tissue depth of 1 cm to the whole body • Lens (Eye) Dose Equivalent (LDE): external radiation dose to the lens of the eye at a tissue depth of 0.3 cm • Shallow Dose Equivalent (SDE,WB): radiation dose to the skin of the whole body at a tissue depth of 0.007 cm • Shallow Dose Equivalent (SDE,ME): radiation dose to the skin of an extremity at a tissue depth of 0.007 cm (arm below the elbow, leg below the knee) • Committed Dose Equivalent (CDE): dose to a specific organ or tissue that will be received from an intake of radioactive material by an individual during the 50-year period following the intake • Committed Effective Dose Equivalent (CEDE): sum of the products of committed dose equivalents for the body organs or tissues multiplied their specific weighting factors What do my numbers mean? State and federal occupational radiation dose limits are set at levels below which there are believed to be negligible health risks to workers.
    [Show full text]
  • Reports Overview
    Reports Overview dosimetry services A Mirion Technologies Division Featuring: TABLE OF CONTENTS Overview.................................................................. 1 Report Definition..................................................... 2-3 Occupational Radiation Exposure........................ 4-5 ALARA Exposure.................................................... 6-7 ALARA Letter........................................................... 8 History Detail........................................................... 9 Annual Individual Summary (Form 5)................... 10-11 Statistical Summary................................................ 12 Total Dose............................................................... 13 Dose Management.................................................. 14-17 Preliminary Dose.................................................... 18 Dose Adjustment Confirmation............................. 19 Dose Estimate......................................................... 20-21 Annual Account Summary..................................... 22-23 Unreturned Badge.................................................. 24 Environmental Monitoring Letter.......................... 25 Environmental Monitoring..................................... 26 Report Requests..................................................... 27 OVERVIEW This Reports Overview booklet provides descriptions and samples of the reports that are available through your service with Mirion Technologies Dosimetry Services Division. Mirion Technologies Dosimetry
    [Show full text]